Courage and Connections: Dan Doctoroff and Stella Sarraf Discuss ALS, Synapses, and Spinogenix’s Innovative Approach

BLOG June 12, 2024 Courage and Connections: Dan Doctoroff and Stella Sarraf Discuss ALS, Synapses, and Spinogenix’s Innovative Approach By: Stella Sarraf, Ph.D., CEO and founder of Spinogenix Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, was first described over 150 years ago. Despite decades of research, it remains an incurable disease with […]

Using EEG and TMS to capture treatment-related Brain Signals in Spinogenix Drug Trials

BLOG Using EEG and TMS to capture treatment-related Brain Signals in Spinogenix Drug Trials Spinogenix is leveraging old and new neurophysiological readouts to maximize signal detection in their human drug trials. This has positive implications for conducting rapid, highly quantitative early phase trials that can significantly aid future development. Drug development is a complicated, expensive, […]